GlassScriptPhysician profile
Ryan J Mauck
NPI 1356541072
$1,485.52
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $125 · 2022: $403 · 2023: $21.66 · 2024: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $490 · Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $489.91 |
| Food and Beverage | $339.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $496.04 | 2024 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $294.15 | 2022-2024 | Aquabeam System |
| Medtronic, INC. | $162.07 | 2022 | |
| Intuitive Surgical, INC. | $99.80 | 2020 | |
| Medtronic USA, INC. | $97.32 | 2019 | |
| Innovation Technologies INC | $49.32 | 2024 | Irrisept |
| Merck Sharp & Dohme LLC | $44.00 | 2022 | |
| Astellas Pharma US INC | $43.16 | 2022 | |
| Coloplast Corp | $38.54 | 2024 | |
| Immunitybio, INC. | $30.98 | 2024 | |
| Olympus America INC. | $28.66 | 2024 | Itind System |
| Boston Scientific Corporation | $24.94 | 2020 | |
| Ferring Pharmaceuticals INC. | $23.54 | 2024 | Adstiladrin |
| Photocure INC | $21.66 | 2023 | Cysview |
| Neotract INC. | $16.39 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mauck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.